Walsh & Associates, LLC

Position in ABBV — AbbVie Inc.

CIK 2135144 SARASOTA, FL

Position in ABBV

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$203,325

+$63,479 QoQ

Shares Held

808

+25.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.99%

of 13F equity value

Holder Rank

#3,947

of 4,153 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Walsh & Associates, LLC holds $774,817 across 6 Drug Manufacturers - General names. ABBV ranks #2 (26.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,615	$410,161
2	ABBV	AbbVie Inc. This page	808	$203,325
3	AMGN	Amgen Inc	250	$90,530
4	LLY	ELI LILLY & Co	45	$53,974
5	GILD	Gilead Sciences, Inc.	100	$12,634
6	GSK	GSK plc	80	$4,193

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,325	808	+25.7%	Shares	Sole	2026-07-21
2026-03-31	$139,846	643	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$146,462	641	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.